|Table of Contents|

Dosimetry study based on tangential arc radiotherapy at the medial margin of mammary gland after radical resection of left breast cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2025 04
Page:
590-597
Research Field:
Publishing date:

Info

Title:
Dosimetry study based on tangential arc radiotherapy at the medial margin of mammary gland after radical resection of left breast cancer
Author(s):
LI HanZHAO BiaoYUAN MeifangLI JingZHU CenchengYANG Yi
Department of Radiotherapy,Yunnan Cancer Hospital,the Third Affiliated Hospital of Kunming Medical University,Peking University Cancer Hospital Yunnan Hospital,Yunnan Kunming 650118,China.
Keywords:
medial margin tangentVMATleft breast cancerradical mastectomydosimetry
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2025.04.007
Abstract:
Objective:To explore the dosimetric difference between medial margin tangential arc and conventional tangential arc in VMAT after radical left mastectomy,provide reference for clinical optimization planning.Methods:36 patients who received radiotherapy after radical mastectomy in our hospital from January 2022 to June 2024 were retrospectively selected.VMAT plans were designed for each patient in two groups:Medial margin tangent (MMTiso) and conventional tangential arc (CTAiso).Target conformity index (CI),homogeneity index (HI),D2,D50,D98 and organ at risk of two groups of plans were collected.The dosimetric differences in planning target volume and organ at risk between the two groups were compared.Results:D98,D2,CI and HI in MMTiso group were better than CTAiso group,the difference was statistically significant (P<0.05).The results of left lung (Dmean,V30,V20,V5),heart(Dmean,V5)and spinal cord(D2) in MMTiso group were lower than those in CTAiso group.The left lung V20 and V5 were (21.02±3.49)% vs (24.39±3.71)%,(48.61±3.64)% vs (53.75±4.19)%,the difference was statistically significant (P<0.05),heart Dmean and V5 were (579.24±161.14)cGy vs (636.21±168.19)cGy,(22.92±6.52)% vs (25.81±6.79)%,the difference was statistically significant (P<0.05).Conclusion:Both plans meet clinical dose requirements.The irradiation mode of medial margin tangent improves the CI and HI of the target area,reduces the dose of left lung (Dmean,V30,V20,V5),heart (Dmean,V5) and spinal cord(D2),to achieve the greater dose benefits for vital organs such as the heart and lungs.Taken together,the medial tangential arc is more advantageous in VMAT radiotherapy planning after radical mastectomy.

References:

[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA-Cancer J Clin,2024,74(3):229-263.
[2] GRADISHAR WJ,MORAN MS,ABRAHAM J,et al.Breast cancer,version 3.2024,NCCN clinical practice guidelines in oncology[J].J Natl Compr Canc NE,2024,22(5):331-357.
[3]DE ROSE F,CARMEN DE SANTIS M,LUCIDI S,et al.Dose constraints in breast cancer radiotherapy.A critical review[J].Radiother Oncol,2024,202:110591.
[4]MADUME R,SINGH RAIT J.Is breast conservation surgery feasible in ipsilateral cancer recurrence with previous radiotherapy[J].J Global Med,2024,4(S1):e191.
[5]BALAJI K,SUBRAMANIAN B,YADAV P,et al.Radiation therapy for breast cancer:Literature review[J].Med Dosim,2016,41(3):253-257.
[6]MISHRA SS,NANDA S,AHIRWAR MK,et al.Advancing precision in post-mastectomy chest wall radiotherapy:A comparative dosimetric analysis of volumetric-modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) based on institutional experience[J].Cureus,2023,15(5):e38464.
[7]KARPF D,SAKKA M,METZGER M,et al.Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT):trade-offs between secondary cancer induction risk and optimal target coverage[J].Radiat Oncol,2019,14(1):156.
[8] LIU H,CHEN X,HE Z,et al.Evaluation of 3D-CRT,IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study[J].Comput Med Imaging Graph,2016,54:1-5.
[9] MANDAL A,ASTHANA AK,PRADHAN S,et al.Search of an ideal location of isocenter in intensity-modulated radiotherapy treatment plans:A dosimetrical approach[J].J Cancer Res Ther,2019,15(1):211-215.
[10]国家癌症中心/国家肿瘤质控中心.乳腺癌术后放疗靶区勾画和计划设计指南[J].中华放射肿瘤学杂志,2022,31(10):863-878.National Cancer Center/National Center for Cancer Quality Control.Guidelines for target delineation and planning design of postoperative radiotherapy for breast cancer[J].Chinese Journal of Radiation Oncology,2022,31(10):863-878.
[11]郭晨雷,徐英杰,戴建荣.乳腺癌容积调强弧形治疗的射野边界外放方法[J].中华放射肿瘤学杂志,2018,27(9):845-849.GUO CL,XU YJ,DAI JR.Margin expansion for treatment field of volumetric modulated arc therapy for breast cancer[J].Chinese Journal of Radiation Oncology,2018,27(9):845-849.
[12]KAUSAR M,GURJAR O,BAGDARE P,et al.Dosimetric analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for chest wall irradiation in breast cancer patients[J].J Radiother Pract,2015,15(1):30-37.
[13]AlSAIHATY Z,ABDUL MANAN H,SABARUDIN A,et al.Hybrid treatment planning for chest wall irradiation utilizing three-dimensional conformal radiotherapy (3DCRT),intensity-modulated radiation therapy (IMRT),and volumetric modulated arc therapy (VMAT):a systematic review[J].Cureus,2024,16(5):e59583.
[14]郝金龙,曾静,曲芃芃.宫颈癌容积旋转调强计划中射野等中心位置的剂量学影响[J].生物医学工程与临床,2022,26(4):450-454.HAO JL,ZENG J,QU PP.Dosimetric effect of isocenter location on cervical cancer volumetric modulated arc therapy plan[J].Biomedical Engineering and Clinical Medicine,2022,26(4):450-454.
[15]SALTER BJ,FUSS M,SARKAR V,et al.Optimization of isocenter location for intensity modulated stereotactic treatment of small intracranial targets[J].Int J Radiat Oncol,2009,73(2):546-555.
[16]杨海芳,刘建平,王志武,等.多等中心调强计划在双侧乳腺癌放射治疗中的应用[J].中华肿瘤防治杂志,2020,27(19):1548-1553.YANG HF,LIU JP,WANG ZW,et al.Application of intensity-modulated radiation therapy with multi-ISO centers planning method for bilateral breast cancer[J].Chinese Journal of Cancer Prevention and Treatment,2020,27(19):1548-1553.
[17]XIE Y,BOURGEOIS D,GUO B,et al.Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery[J].Med Dosim,2020,45(4):e9-e16.
[18]HALL EJ,WUU CS.Radiation-induced second cancers:the impact of 3D-CRT and IMRT[J].Int J Radiat Oncol,2003,56(1):83-88.
[19]吴华玲,林清.乳腺癌调强放疗后放射性肺炎的临床和剂量学相关因素分析[J].中国癌症防治杂志,2024,16(3):327-331.WU HL,LIN Q.Analysis of clinical and dosimetric factors related to radiation pneumonitis after intensity-modulated radiotherapy in breast cancer[J].Chinese Journal of Oncology Prevention and Treatment,2024,16(3):327-331.
[20]KONKOL M,SNIATALA P,MILECKI P.Radiation-induced lung injury-what do we know in the era of modern radiotherapy[J].Rep Pract Oncol Radi,2022,27(3):552-565.
[21]KUNDRAT P,REMMELE J,RENNAU H,et al.Inter-patient variability in doses to nearby organs in breast-cancer radiotherapy:inference from anatomic features[J].Radiat Prot Dosim,2019,183(1-2):255-258.
[22]INSKIP PD,STOVALL M,FLANNERY JT.Lung cancer risk and radiation dose among women treated for breast cancer[J].JNCI-J Natl Cancer I,1994,86(13):983-988.
[23]蒲琴,赵彪,袁美芳,等.基于内缘切线拉弧的VMAT在左侧乳腺癌保乳术后放疗中的应用[J].现代肿瘤医学,2024,32(8):1480-1485.PU Q,ZHAO B,YUAN MF,et al.Application of volumetric modulated arc therapy based on inner edge tangential arc for left breast cancer patients after breast-conserving surgery[J].Modern Oncology,2024,32(8):1480-1485.
[24]QIU J,ZHANG S,LV B,et al.Cardiac dose control and optimization strategy for left breast cancer radiotherapy with non-uniform VMAT technology[J].Technol Cancer Res T,2021,20:15330338211053752.
[25]陈美琴,周玲,丁叔波.VMAT技术用于乳腺癌改良根治术后放疗患者的剂量学研究[J].现代实用医学,2024,36(10):1359-1362.CHEN MQ,ZHOU L,DING SB.Dosimetry study of VMAT technique in patients with radiotherapy after modified radical surgery for breast cancer[J].Modern Practical Medicine,2024,36(10):1359-1362.
[26]SARDARO A,MCDONALD F,BARDOSCIA L,et al.Dyspnea in patients receiving radical radiotherapy for non-small cell lung cancer:A prospective study[J].Front Oncol,2020,10:594590.
[27]SAIKI H,PETERSEN IA,SCOTT CG,et al.Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer[J].Circulation,2017,135(15):1388-1396.
[28]HU J,HAN G,LEI Y,et al.Dosimetric comparison of three radiotherapy techniques in irradiation of left-sided breast cancer patients after radical mastectomy[J].Biomed Res Int,2020,2020:7131590.
[29]WANG R,SHEN J,YAN H,et al.Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in patients of left-sided breast cancer treated with modified radical mastectomy[J].Consort Medicine,2022,101(2):e28427.
[30]AIHARA T,TANAKA S,SAGARA Y,et al.Incidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapy[J].Breast Cancer-Tokyo,2012,21(3):284-291.
[31]中国医师协会放射肿瘤治疗医师分会.乳腺癌放射治疗指南(中国医师协会2020版)[J].中华放射肿瘤学杂志,2021,30(4):321-342.Chinese Medical Doctor Association Radiation Oncologist Branch.Guidelines for radiotherapy of breast cancer (Chinese Medical Doctor Association 2020 edition)[J].Chinese Journal of Radiation Oncology,2021,30(4):321-342.

Memo

Memo:
National Natural Science Foundation of China(No.32360114);国家自然科学基金资助项目(编号:32360114)
Last Update: 1900-01-01